CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 80 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $287,000 | -34.0% | 49,122 | -24.3% | 0.02% | -40.5% |
| Q3 2022 | $435,000 | +48.0% | 64,903 | -8.7% | 0.04% | +85.0% |
| Q2 2022 | $294,000 | +12.2% | 71,101 | 0.0% | 0.02% | +17.6% |
| Q1 2022 | $262,000 | +11.5% | 71,101 | -4.7% | 0.02% | +21.4% |
| Q4 2021 | $235,000 | -47.8% | 74,623 | -45.7% | 0.01% | -44.0% |
| Q3 2021 | $450,000 | -23.3% | 137,506 | -1.2% | 0.02% | -24.2% |
| Q2 2021 | $587,000 | – | 139,106 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 2,610 | $620,000,000 | 6.47% |
| Parkman Healthcare Partners LLC | 1,124,072 | $4,732,000 | 1.74% |
| Kynam Capital Management, LP | 1,000,000 | $4,210,000 | 1.08% |
| EAM Investors, LLC | 850,647 | $3,581,000 | 0.87% |
| BVF INC/IL | 3,629,000 | $15,278,000 | 0.74% |
| EAM Global Investors LLC | 388,730 | $1,637,000 | 0.40% |
| RA Capital Management | 3,307,203 | $13,923,000 | 0.37% |
| Nantahala Capital Management | 1,659,840 | $6,988,000 | 0.35% |
| AWM Investment Company, Inc. | 504,661 | $2,125,000 | 0.34% |
| INGALLS & SNYDER LLC | 1,411,153 | $5,941,000 | 0.31% |